Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 37Recruiting 30Not yet recruiting 8Completed 8Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Head & Neck 1

Conditions

Melanoma 1Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck 1

Interventions

pembrolizumab 9fludarabine phosphate 5fludarabine 5atezolizumab 4Paclitaxel 4Nivolumab 4Cyclophosphamide 4Cisplatin 4Cetuximab 4Carboplatin 4durvalumab 3Specimen Handling 3Pemetrexed 3Docetaxel 3Bevacizumab 3venetoclax 2ibrutinib 2encorafenib 2binimetinib 2Trastuzumab 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Practice Guidelines as Topic 2Platinum 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Leucovorin 2Ipilimumab 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Radiotherapy × 30 days × Clear all
NCT05110781 2026-06-05

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

University of California, Davis

Phase 2 Terminated
1 enrolled 9 charts
DermatologicHead & Neck

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT03958383 2026-06-03

IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma

University of Wisconsin, Madison

Phase 1/2 Terminated
8 enrolled 12 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡